| Sickle-cell disease DC Rees, TN Williams, MT Gladwin The Lancet 376 (9757), 2018-2031, 2010 | 2727 | 2010 |
| World distribution of factor V Leiden DC Rees, M Cox, JB Clegg Lancet (London, England) 346 (8983), 1133-1134, 1995 | 1725 | 1995 |
| Sickle cell disease FB Piel, MH Steinberg, DC Rees New England Journal of Medicine 376 (16), 1561-1573, 2017 | 1380 | 2017 |
| Geographic distribution of the 20210 G to A prothrombin variant FR Rosendaal, CJM Doggen, A Zivelin, VR Arruda, M Aiach, DS Siscovick, ... Thrombosis and haemostasis 79 (04), 706-708, 1998 | 1005 | 1998 |
| Global distribution of the CCR5 gene 32-basepair deletion JJ Martinson, NH Chapman, DC Rees, YT Liu, JB Clegg Nature genetics 16 (1), 100-103, 1997 | 755 | 1997 |
| Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ... Thrombosis and haemostasis 86 (09), 809-816, 2001 | 542 | 2001 |
| Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria M Balwani, E Sardh, P Ventura, PA Peiró, DC Rees, U Stölzel, DM Bissell, ... New England journal of medicine 382 (24), 2289-2301, 2020 | 467 | 2020 |
| FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high‐risk group FM Abu‐Duhier, AC Goodeve, GA Wilson, MA Gari, IR Peake, DC Rees, ... British journal of haematology 111 (1), 190-195, 2000 | 426 | 2000 |
| Worldwide distribution of a common methylenetetrahydrofolate reductase mutation JA Schneider, DC Rees, YT Liu, JB Clegg The American Journal of Human Genetics 62 (5), 1258-1260, 1998 | 419 | 1998 |
| Significant haemoglobinopathies: guidelines for screening and diagnosis. K Ryan, BJ Bain, D Worthington, J James, D Plews, A Mason, D Roper, ... British journal of haematology 149 (1), 2010 | 382 | 2010 |
| Guidelines for the management of the acute painful crisis in sickle cell disease DC Rees, AD Olujohungbe, NE Parker, AD Stephens, P Telfer, J Wright, ... British journal of haematology 120 (5), 744-752, 2003 | 332 | 2003 |
| Silica, silicosis and tuberculosis D Rees, J Murray Occupational Health Southern Africa 26 (5), 266-276, 2020 | 318 | 2020 |
| Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency S Sumi, AM Marinaki, M Arenas, L Fairbanks, M Shobowale-Bakre, ... Human genetics 111, 360-367, 2002 | 299 | 2002 |
| Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis E Fotiou, S Martin-Almedina, MA Simpson, S Lin, K Gordon, G Brice, ... Nature communications 6 (1), 8085, 2015 | 297 | 2015 |
| The spleen and sickle cell disease: the sick (led) spleen V Brousse, P Buffet, D Rees British journal of haematology 166 (2), 165-176, 2014 | 273 | 2014 |
| Phase 1 trial of an RNA interference therapy for acute intermittent porphyria E Sardh, P Harper, M Balwani, P Stein, D Rees, DM Bissell, R Desnick, ... New England Journal of Medicine 380 (6), 549-558, 2019 | 256 | 2019 |
| The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial J Howard, M Malfroy, C Llewelyn, L Choo, R Hodge, T Johnson, S Purohit, ... The Lancet 381 (9870), 930-938, 2013 | 245 | 2013 |
| The population genetics of factor V Leiden (Arg506Gln) DC Rees British journal of haematology 95 (4), 579-586, 1996 | 224 | 1996 |
| Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis LAJ Kluijtmans, M Den Heijer, PH Reitsma, SG Heil, HJ Blom, ... Thrombosis and haemostasis 79 (02), 254-258, 1998 | 206 | 1998 |
| Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. DC Rees, H Kelsey, JD Richards BMJ: British Medical Journal 306 (6881), 841, 1993 | 201 | 1993 |
Baba (PDB) Inusapaediatric haematology在 gstt.nhs.uk 的电子邮件经过验证
